Immunotherapy — redirecting patients’ highly individual immune systems to target, detect, and destroy cancer cells — is one of the most promising avenues of cancer research today. Johns Hopkins is on the cutting edge of this rapidly advancing approach to treatment and potentially a cure, thanks to the pathbreaking work being done at the Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Launched in March 2016 with $50 million gifts from Michael R. Bloomberg and Sidney Kimmel, along with an additional $25 million contributed by other supporters, the institute will further strengthen Johns Hopkins’ world-class program in cancer immunology, uniting the Johns Hopkins Kimmel Cancer Center experts with the immunology, genetics, microbiology, and biomedical engineering experts throughout Johns Hopkins in a concentrated effort involving more than 100 scientists and clinicians.

As then Vice President Joe Biden said at the launch of the institute, “I’m convinced that not only will we save millions of lives, we will reinstill in the American public the notion that anything is possible.”